Angina: Symptoms, Causes & Treatment Center in Manhattan, NY

Angina

Angina Pectoris: Symptoms, Types, Causes & Integrative Treatment in NYC

Angina is chest pain caused by insufficient blood flow through narrowed coronary arteries — a warning signal that your heart muscle is struggling to receive the oxygen it needs. For patients, each episode can feel alarming and isolating; a gripping pressure that disrupts work, exercise, and peace of mind.

10M+

Americans diagnosed with angina annually

70%

Of cases are caused by obstructive coronary artery disease

2–15 min

Typical duration of a stable angina episode

50%

Reduction in events possible with comprehensive lifestyle intervention

Medically reviewed by Dr. Rashmi Gulati, MD — Medical Director, Patients Medical.

Board-certified integrative medicine physician.

Clinical Definition

Angina pectoris is a clinical syndrome characterised by episodic chest pain or pressure arising from transient myocardial ischaemia — an imbalance between myocardial oxygen supply and demand — most commonly resulting from atherosclerotic narrowing of the coronary arteries. The discomfort is typically precipitated by physical exertion, emotional stress, cold exposure, or a heavy meal, and is relieved within 2–15 minutes by rest or sublingual nitroglycerin. Angina is categorised as stable (predictable, exertion-related), unstable (unpredictable, rest-onset, medical emergency), or variant (Prinzmetal’s — caused by coronary artery spasm rather than fixed plaque).

Key Symptoms

Chest pressure or tightness on exertion
Pain radiating to left arm or jaw
Shortness of breath during activity
Fatigue and exercise intolerance
Diaphoresis (excessive sweating)
Nausea and indigestion-like discomfort

Primary Causes

Nausea and indigestion-like discomfort
Dyslipidaemia with elevated ApoB particles
Chronic vascular inflammation (elevated hs-CRP)
Hypertension and endothelial dysfunction
Insulin resistance and metabolic syndrome
Elevated lipoprotein(a) or homocysteine

Treatment Approach

Advanced cardiovascular biomarker testing
Anti-inflammatory nutritional protocol
CoQ10, omega-3, magnesium supplementation
Supervised graded exercise rehabilitation
Chelation therapy (where indicated)
Stress and autonomic nervous system rebalancing

What is Angina Pectoris?

Angina pectoris — from the Latin for “strangling in the chest” — is chest pain or discomfort that occurs when the heart muscle temporarily receives less blood and oxygen than it needs. In most cases, this happens because one or more of the coronary arteries (the vessels that feed the heart muscle itself) have become narrowed by atherosclerotic plaque — fatty, calcium-containing deposits that build up inside artery walls over years of metabolic and inflammatory stress. When you are resting, a narrowed coronary artery may still allow adequate blood flow. But when you exercise, climb stairs, or become emotionally stressed, your heart rate increases, your heart muscle demands more oxygen, and the narrowed artery cannot keep up. The result is the distinctive pressure, tightness, or squeezing sensation that patients describe as a “band around the chest,” “an elephant sitting on my sternum,” or “a deep ache that goes into my arm.”

At the biological level, when myocardial oxygen delivery falls below demand, the affected heart muscle cells switch from aerobic to anaerobic metabolism, producing lactic acid and triggering the pain-signalling pathways of the cardiac sympathetic nerves. This is the mechanism behind the discomfort you feel — and it is the same pathway that, if oxygen deprivation becomes complete and prolonged, leads to a heart attack. Angina, therefore, is not merely chest pain; it is a critical early warning signal that coronary artery disease has reached a clinically significant threshold.

From a functional medicine perspective, angina represents the downstream consequence of years of upstream metabolic disruption — chronic inflammation, insulin resistance, dyslipidaemia characterised by elevated small dense LDL particles and oxidised LDL, elevated homocysteine, heavy metal toxicity, and endothelial dysfunction. Standard cardiology addresses angina’s acute consequences (symptom relief, revascularisation) and does this essential work well. Functional medicine addresses the root causes driving disease progression: correcting the metabolic environment that generated the atherosclerotic plaques and continues to drive their growth.

Angina affects more than 10 million Americans and is more prevalent in men before the age of 65; however, after menopause, women’s rates converge with men’s as oestrogen-mediated cardiovascular protection diminishes. The condition is a leading cause of emergency room visits and one of the most powerful predictors of future myocardial infarction. With comprehensive management — combining conventional cardiological care and rigorous functional medicine assessment — many patients achieve meaningful reduction in symptom frequency and long-term cardiovascular risk.

Coronary Arteries

The left anterior descending (LAD), right coronary artery (RCA), and left circumflex artery (LCx) supply oxygenated blood to the myocardium. Atherosclerotic narrowing of any of these vessels reduces flow reserve, triggering ischaemia during exertion.

Myocardium (Heart Muscle)

The cardiac muscle requires a continuous, high-volume supply of oxygen because it contracts 60–100 times per minute without rest. Unlike skeletal muscle, it cannot tolerate prolonged oxygen deprivation — even brief ischaemia causes functional impairment and, if sustained, irreversible cell death.

Vascular Endothelium

The single-cell layer lining every blood vessel regulates vascular tone, inflammation, and platelet activation. Endothelial dysfunction — driven by oxidised LDL, elevated blood glucose, and systemic inflammation — is the initiating step in atherosclerotic plaque formation and a key target of functional medicine intervention.

Signs & Symptoms of Angina

Angina symptoms span multiple body systems because the heart’s reduced pumping efficiency affects circulation, energy production, and neural signalling throughout the body — and atypical presentations without classic chest pain are more common than most patients realise.

Chest & Cardiovascular Symptoms

Chest Pressure or Tightness

The hallmark of angina — a squeezing, heavy, or constricting sensation typically located retrosternally (behind the breastbone), caused by cardiac sympathetic nerve activation during myocardial ischaemia.

Radiating Pain to Left Arm, Jaw, or Neck

Cardiac pain signals travel through the same spinal pathways as pain from the left arm and jaw (referred pain), causing the characteristic radiation pattern that distinguishes angina from musculoskeletal chest pain.

Palpitations or Irregular Heartbeat

Ischaemia disrupts normal cardiac electrical conduction, potentially triggering premature ventricular contractions (PVCs) or atrial arrhythmias during episodes of reduced coronary blood flow.

Rapid Heart Rate on Exertion

Compensatory tachycardia — the heart beating faster to maintain cardiac output — paradoxically worsens ischaemia by increasing myocardial oxygen demand while reducing diastolic filling time.

Upper Abdominal Discomfort

The inferior myocardium shares referred pain pathways with the upper gastrointestinal tract, leading some patients to experience inferior-territory ischaemia as epigastric pain or indigestion — a common cause of misdiagnosis.

Respiratory & Energy Symptoms

Shortness of Breath on Exertion

When ischaemia impairs left ventricular function, cardiac output drops and pulmonary venous pressure rises, causing fluid transudation into the lung alveoli and the sensation of breathlessness — even without chest pain (common in women and older adults).

Profound Fatigue During Activity

Reduced coronary blood flow limits cardiac output, decreasing oxygen delivery to exercising skeletal muscles and generating premature lactic acid accumulation — the same mechanism that causes muscular fatigue under anaerobic conditions.

Exercise Intolerance

Patients develop a consistent "anginal threshold" — an exertion level above which symptoms reliably appear — that progressively lowers as coronary artery disease advances, leading to curtailed activity and physical deconditioning.

Nocturnal Breathlessness (Variant Angina)

Coronary artery spasm (Prinzmetal's angina) can occur during sleep when autonomic tone shifts, causing rest-onset breathlessness and chest discomfort — distinct from stable exertional angina.

Orthopnoea (Breathlessness Lying Flat)

In patients with significant left ventricular dysfunction from chronic ischaemia, lying flat redistributes blood volume to the thorax, worsening pulmonary congestion and prompting patients to sleep propped up on pillows.

Neurological & Psychological Symptoms

Dizziness or Lightheadedness

Transient reductions in cardiac output during ischaemic episodes can decrease cerebral blood flow, producing presyncope — a frightening sensation that often accompanies severe angina episodes.

Anxiety and Sense of Impending Doom

Cardiac ischaemia activates the sympathetic nervous system acutely, triggering catecholamine release that produces anxiety, apprehension, and the visceral sense that something is seriously wrong — a response that is biologically adaptive but psychologically distressing.

Cognitive Fog or Difficulty Concentrating

Reduced cerebral perfusion associated with compromised cardiac output, as well as the heightened sympathetic arousal during and after angina episodes, impairs working memory and executive function.

Generalised Weakness

The combination of reduced skeletal muscle perfusion, sympathetic activation, and compensatory metabolic shifts during ischaemia produces a systemic weakness and malaise that patients often describe as being "drained" after an angina episode.

Poor Sleep Quality

Both the anxiety associated with angina diagnosis and the overnight autonomic changes that can precipitate variant angina episodes disrupt sleep architecture, worsening cardiovascular risk through neuroendocrine dysregulation.

Metabolic & Constitutional Symptoms

Diaphoresis (Cold Sweating)

Intense sympathetic nervous system activation during ischaemia triggers eccrine sweat glands throughout the body, producing the characteristic cold, clammy sweat that distinguishes cardiac from non-cardiac chest pain.

Nausea

Vagal afferent nerve activation from the ischaemic myocardium stimulates the dorsal vagal nucleus, producing nausea that is especially prominent in inferior wall ischaemia — again, a common atypical presentation that leads to misdiagnosis as gastrointestinal illness.

Pallor or Cyanosis

Peripheral vasoconstriction (sympathetically mediated) and reduced cardiac output during significant ischaemic events divert blood from skin circulation, producing paleness or, in severe cases, a greyish skin tone.

Elevated Resting Blood Pressure

Chronic sympathetic activation, endothelial dysfunction, and arterial stiffness — all associated with the underlying coronary artery disease that drives angina — commonly co-exist with and worsen hypertension, increasing the heart's workload.

Reduced Physical Stamina Over Time

Progressive coronary artery disease gradually lowers the anginal threshold, meaning patients find themselves symptomatic at ever-lower exertion levels — a clinical signal of disease progression that warrants urgent re-evaluation.

The 4 Types of Angina: What Your Presentation Reveals

Understanding which type of angina you have is clinically critical — it determines the urgency of evaluation, the underlying mechanism driving symptoms, and the appropriate treatment pathway. Each type carries a distinct prognosis and management strategy.

01 Type I: Predictable Pattern

Stable Angina

Stable angina is the most common form, characterised by chest pain or discomfort that appears predictably with exertion, emotional stress, cold exposure, or a heavy meal — and reliably resolves within 2–15 minutes of rest or after sublingual nitroglycerin. The underlying mechanism is fixed atherosclerotic plaque narrowing one or more coronary arteries to a degree that limits blood flow only when oxygen demand increases. Episodes are consistent in character, duration, and trigger threshold.

Who gets this: Adults over 50, more common in men before 65, patients with known cardiovascular risk factors including hypertension, dyslipidaemia, or type 2 diabetes.

02 Type II: Medical Emergency

Unstable Angina

Unstable angina is a medical emergency characterised by chest pain that is new in onset, worsening in frequency or severity, occurring at rest, or not fully relieved by nitroglycerin. It results from acute plaque rupture or erosion triggering partial blood clot (thrombus) formation within a coronary artery — partially obstructing flow without causing complete infarction. Troponin levels are not elevated (distinguishing it from NSTEMI), but near-term infarction risk is very high and immediate hospitalisation is mandatory.

Who gets this: Any age with known or undiagnosed coronary artery disease; often the first presentation of previously undetected heart disease. Requires same-day emergency evaluation.

03 Type III: Vasospastic Origin

Variant (Prinzmetal's) Angina

Variant angina is caused by transient coronary artery spasm — a sudden constriction of the coronary artery wall that temporarily blocks blood flow — rather than fixed atherosclerotic plaque. Episodes characteristically occur at rest, often in the early morning hours between midnight and 8 a.m., and may be associated with ST-segment elevation on ECG during the episode. Triggers include cocaine use, cigarette smoking, cold exposure, and emotional stress. Coronary arteries may appear normal or near-normal on angiography.

Who gets this: Younger patients (30s–50s), women more than men in some studies, smokers, and those with autoimmune inflammatory conditions that increase vascular reactivity.

04 Type IV: Microvascular

Microvascular Angina (Cardiac Syndrome X)

Microvascular angina — also called Cardiac Syndrome X or INOCA (Ischaemia with Non-Obstructive Coronary Arteries) — occurs when the tiny microvasculature of the heart (coronary microvessels too small to see on standard angiography) fails to dilate adequately during exertion. Normal or near-normal coronary angiography in the presence of genuine ischaemic symptoms characterises this syndrome. It is driven by microvascular endothelial dysfunction, insulin resistance, and chronic low-grade inflammation. Historically under-diagnosed, it is increasingly recognised as a clinically significant cause of angina, particularly in women.

Who gets this: Predominantly women (particularly post-menopausal), patients with insulin resistance or metabolic syndrome, and those with autoimmune conditions and systemic inflammation.

What Causes Angina? Root Causes & Risk Factors Explained

Angina rarely has a single cause — it is the clinical expression of years of interacting metabolic, inflammatory, and lifestyle factors that progressively impair coronary artery function and blood flow capacity.

01

Atherosclerotic Coronary Artery Disease

Accumulation of lipid-laden, calcified plaques within coronary artery walls progressively narrows the vessel lumen, reducing coronary flow reserve — the primary driver of stable angina in 70% of cases.

02

Dyslipidaemia with Elevated ApoB Particles

Elevated small dense LDL particles, high ApoB concentration, and low HDL are the lipid drivers of plaque formation — standard cholesterol panels frequently miss elevated atherogenic particle burden in patients with “normal” LDL cholesterol.

03

Chronic Vascular Inflammation (Elevated hs-CRP)

Systemic low-grade inflammation — measured by high-sensitivity C-reactive protein (hs-CRP) — accelerates endothelial injury, oxidises LDL particles (making them more atherogenic), and destabilises existing plaques, raising acute coronary syndrome risk.

04

Hypertension

Elevated blood pressure increases cardiac workload (myocardial oxygen demand), accelerates atherosclerosis through endothelial shear stress, and promotes left ventricular hypertrophy — a structural change that further impairs coronary perfusion of the thickened heart wall.

05

Insulin Resistance & Type 2 Diabetes

Chronic hyperglycaemia and hyperinsulinaemia glycate arterial wall proteins, increase vascular oxidative stress, promote endothelial dysfunction, and raise triglycerides and small dense LDL — creating multiple simultaneous pathways for coronary artery disease progression.

06

Elevated Lipoprotein(a) — Lp(a)

Lipoprotein(a) is a genetically determined, independent cardiovascular risk factor carried by approximately 20% of the population that promotes thrombosis, inhibits fibrinolysis, and delivers oxidised phospholipids to arterial plaques — a factor missed by standard lipid panels.

07

Hyperhomocysteinaemia

Elevated plasma homocysteine — driven by deficiency of folate, B12, B6, or MTHFR gene polymorphisms — directly damages the vascular endothelium, promotes smooth muscle proliferation within artery walls, and enhances platelet aggregation.

08

Cigarette Smoking

Tobacco smoke generates massive vascular oxidative stress, constricts coronary arteries acutely, reduces HDL cholesterol, accelerates endothelial dysfunction, and promotes arterial plaque instability — making it the single most reversible cardiovascular risk factor.

09

Heavy Metal Toxicity (Lead & Cadmium)

Chronic low-level lead and cadmium exposure — increasingly documented in urban populations through water, food, and occupational sources — promotes endothelial dysfunction, oxidative stress, hypertension, and accelerated atherosclerosis, constituting an under-recognised cardiovascular risk factor.

10

Sedentary Lifestyle & Physical Deconditioning

Physical inactivity reduces cardiac collateral circulation, worsens metabolic syndrome components, increases resting sympathetic tone, and lowers the anginal threshold — creating a vicious cycle where symptom avoidance leads to the deconditioning that worsens symptoms.

11

Chronic Psychological Stress

Persistent activation of the HPA axis and sympathetic nervous system elevates cortisol and catecholamines chronically — raising blood pressure, promoting abdominal adiposity, impairing glycaemic control, and increasing inflammatory markers, all of which drive coronary artery disease progression.

12

Hormonal Decline (Post-Menopausal Oestrogen Loss)

Oestrogen exerts vasodilatory, anti-inflammatory, and lipid-modifying cardiovascular protective effects. Its withdrawal at menopause is associated with accelerated LDL oxidation, reduced HDL, impaired endothelial nitric oxide synthesis, and a surge in cardiovascular event rates in women after age 55.

Angina vs. Related Cardiovascular Conditions

Several cardiovascular and non-cardiac conditions produce chest pain or dyspnoea that overlaps with angina presentation — accurate differentiation is essential because management strategies differ significantly.

Feature	Stable Angina	Myocardial Infarction (Heart Attack)	Heart Failure	GERD / Oesophageal Spasm
Key Biomarker	Elevated hs-CRP; reduced coronary flow reserve on stress test	Troponin I or T elevated (confirming myocyte necrosis)	BNP / NT-proBNP elevated; reduced LVEF on echo	Normal cardiac biomarkers; may have oesophageal manometry abnormality
Best Diagnostic Test	Exercise stress ECG; CAC scoring CT; coronary angiography	Serial troponin blood tests + ECG ST changes	Echocardiogram + BNP blood test	Upper endoscopy; oesophageal pH monitoring; manometry
Hallmark Symptom	Predictable chest pressure with exertion, relieved by rest	Severe crushing chest pain lasting >20 minutes; not relieved by rest	Exertional breathlessness; oedema; orthopnoea; paroxysmal nocturnal dyspnoea	Burning chest pain after meals; worse lying down; acid taste; relieved by antacids
Standard Blood Test Detection	May be missed on basic lipid panel; requires advanced lipid + hs-CRP	Elevated troponin, CK-MB; reliably detected on standard cardiac panel	Elevated BNP; electrolyte abnormalities; detected on standard metabolic panel	Not detected on blood tests; normal cardiac enzymes
Treatment Approach	Anti-anginal medications; risk factor modification; revascularisation if indicated; functional medicine root-cause work	Emergency reperfusion (PCI / thrombolysis); antiplatelet therapy; cardiac rehab	ACE inhibitors; beta-blockers; diuretics; cardiac rehabilitation; dietary sodium restriction	Proton pump inhibitors; dietary modification; oesophageal motility therapy
Key Overlap	—	Unstable angina can evolve into MI; requires same emergency evaluation pathway	Ischaemic cardiomyopathy — coronary artery disease causing heart failure — means both conditions frequently coexist	Oesophageal pain can precisely mimic angina; may coexist in same patient and be triggered by the same stressors

Critical clinical overlap: Unstable angina and non-ST-elevation myocardial infarction (NSTEMI) exist on the same acute coronary syndrome spectrum — both present with rest pain and ECG changes but are distinguished by troponin elevation (positive = NSTEMI). Any patient with new rest-onset chest pain should be evaluated in an emergency setting immediately. Additionally, ischaemic cardiomyopathy — heart failure caused by coronary artery disease — frequently coexists with angina, and treatment must address both conditions simultaneously.

How We Diagnose Angina in NYC: Advanced Cardiovascular Testing

Standard cardiology testing tells you whether angina is present and how severe it is. Our functional medicine approach goes further — identifying every modifiable biological driver of your coronary artery disease so we can address root causes, not just manage symptoms.

01 Advanced Lipid Panel with ApoB and LDL Particle Number

Standard total LDL cholesterol is a poor predictor of atherosclerotic risk in up to 50% of patients. The advanced lipid panel measures ApoB (total atherogenic lipoprotein particle count), LDL particle number, small dense LDL (sdLDL), and oxidised LDL — the actual drivers of endothelial plaque formation. Many patients with “normal” LDL have dangerously elevated particle burden that explains their angina despite apparently reassuring standard labs. We also measure lipoprotein(a), which is genetically elevated in 20% of the population and doubles cardiovascular risk independently of other factors.

02 High-Sensitivity C-Reactive Protein (hs-CRP) & Inflammatory Panel

Vascular inflammation is both a cause and a consequence of coronary artery disease. High-sensitivity CRP (hs-CRP) at >2.0 mg/L predicts cardiovascular events independently of cholesterol and is modifiable through targeted anti-inflammatory protocols. We also assess interleukin-6 (IL-6), fibrinogen, and Lp-PLA2 (lipoprotein-associated phospholipase A2) — a specific marker of arterial plaque inflammation that standard inflammatory panels miss. Together, these biomarkers map the inflammatory terrain driving your coronary disease.

03 Coronary Artery Calcium (CAC) Scoring CT Scan

A coronary artery calcium CT scan is a low-dose, non-invasive imaging test that directly measures calcified atherosclerotic plaque burden within the coronary arteries, generating a CAC score from 0 to over 1000. A score of zero means effectively no calcified plaque is present — a powerful reassurance. A score above 100 indicates significant disease burden. The CAC score is one of the strongest independent predictors of future cardiac events available in preventive cardiology and directly guides the aggressiveness of lifestyle and pharmacological intervention we recommend.

04 Metabolic & Insulin Resistance Panel

Insulin resistance drives coronary artery disease through multiple parallel pathways and is present in most angina patients — yet standard fasting glucose is a late and insensitive marker. We measure fasting insulin, HOMA-IR (homeostatic model assessment of insulin resistance), haemoglobin A1c, adiponectin, and uric acid alongside a full thyroid panel, as hypothyroidism raises LDL and accelerates atherogenesis. Comprehensive metabolic assessment identifies every modifiable metabolic contributor to your coronary risk.

05 Heavy Metal Testing (Lead, Cadmium, Arsenic)

Chronic low-level heavy metal toxicity — particularly lead, cadmium, and arsenic — is an increasingly documented cause of hypertension, endothelial dysfunction, and accelerated atherosclerosis that is entirely missed by standard cardiac workups. We assess blood and urine heavy metal levels using inductively coupled plasma mass spectrometry (ICP-MS), the gold standard for detection of clinically relevant metal burden. In patients with unexplained coronary artery disease severity or hypertension, metal toxicity testing frequently reveals modifiable contributing factors that chelation therapy can address.

Does This Sound Like You?

Check any symptoms that apply to help guide your consultation.

Chest tightness or pressure that comes on with exercise or stress
Pain that radiates to my left arm, jaw, or neck
Shortness of breath at exertion levels that didn't affect me before
Symptoms consistently relieve when I stop and rest for a few minutes
Unexplained fatigue during physical activity
Palpitations, sweating, or nausea accompanying chest discomfort
Normal or borderline cholesterol but still experiencing chest symptoms
Family history of heart attack or coronary artery disease before age 65
Diagnosed with hypertension, diabetes, or metabolic syndrome

Angina Treatment at Patients Medical NYC

Our treatment philosophy for angina does not begin with symptom suppression — it begins with a comprehensive map of every biological factor driving your coronary artery disease, followed by a personalised protocol addressing each layer of the problem.

Advanced Nutraceutical Cardiovascular Protocol

Targeted supplementation is the backbone of our functional medicine approach to coronary risk reduction. Coenzyme Q10 (200–400 mg/day) — particularly critical for patients on statin therapy, which depletes CoQ10 — supports mitochondrial energy production in cardiac cells and reduces angina frequency in controlled trials. Omega-3 fatty acids (EPA+DHA, 3–4 g/day) reduce triglycerides by up to 45%, lower vascular inflammation, decrease platelet aggregation, and modestly reduce blood pressure. L-carnitine (2 g/day) facilitates fatty acid entry into cardiac mitochondria and has been shown in meta-analyses to reduce angina frequency and improve exercise tolerance.

CoQ10 200–400mg

Omega-3 EPA/DHA

L-Carnitine 2g

Magnesium Glycinate

Berberine

Nattokinase

Advanced Lipid & Inflammatory Biomarker Management

We combine comprehensive biomarker monitoring with targeted nutritional and supplement protocols to lower atherogenic particle burden (ApoB, LDL particle number), reduce vascular inflammation (hs-CRP, IL-6, Lp-PLA2), and optimise HDL function. For patients requiring pharmaceutical lipid therapy, we work collaboratively with your cardiologist to ensure CoQ10 repletion and metabolic support alongside statin therapy. Our goal is not just reaching a cholesterol number — it is achieving a fully optimised cardiovascular biomarker profile that reflects genuine reduced disease risk.

ApoB Reduction Protocol

hs-CRP Monitoring

Oxidised LDL Reduction

HDL Optimisation

Chelation Therapy for Vascular Heavy Metal Burden

The TACT trial (Trial to Assess Chelation Therapy), published in JAMA, demonstrated that intravenous EDTA chelation therapy significantly reduced cardiovascular events in patients with prior myocardial infarction, with the greatest benefit seen in diabetic patients. Chelation removes atherogenic heavy metals (lead, cadmium, mercury) from arterial walls and plaque, reduces oxidative stress, and improves endothelial function. We offer both IV EDTA chelation and oral chelation protocols based on your heavy metal testing results and clinical picture. Chelation is integrated into your broader cardiovascular protocol, not used in isolation.

IV EDTA Chelation

Heavy Metal Removal

Oxidative Stress Reduction

TACT Protocol

Supervised Cardiac Rehabilitation Exercise Protocol

Graded aerobic exercise — performed at 50–70% of maximum heart rate, below the anginal threshold, and progressively extended over 12 weeks — is one of the most evidence-supported non-pharmacological interventions for angina. Regular aerobic training improves coronary collateral circulation (the heart grows new blood supply pathways), reduces resting heart rate (lowering myocardial oxygen demand), lowers inflammatory biomarkers, improves endothelial nitric oxide synthesis, and raises the exercise threshold at which angina occurs. We provide personalised exercise prescriptions with heart rate targets based on your stress test results, with scheduled follow-up to adjust intensity safely.

Graded Aerobic Protocol

Heart Rate Zone Training

Collateral Circulation

Exercise ECG Monitoring

Autonomic Nervous System & Stress Rebalancing

Chronic psychological stress is not a soft risk factor for coronary artery disease — it is a physiologically active driver of plaque progression, arrhythmia risk, and acute coronary events. Activation of the HPA axis chronically elevates cortisol, promotes abdominal adiposity, impairs glycaemic control, and raises inflammatory markers. Sympathetic dominance increases resting heart rate, blood pressure, and coronary vasomotor tone. We address the autonomic nervous system dimension of angina through structured parasympathetic activation techniques, biofeedback-guided heart rate variability (HRV) training, and mindfulness-based stress reduction (MBSR), all of which have demonstrated measurable cardiovascular benefit in clinical trials.

HRV Biofeedback

MBSR Protocol

Cortisol Regulation

4-7-8 Breathing

IV Nutrient Therapy for Cardiovascular Support

Intravenous nutrient therapy delivers high-dose cardiovascular-supportive nutrients directly into the bloodstream, bypassing gastrointestinal absorption limitations and achieving therapeutic tissue concentrations that oral supplementation alone cannot always reach. Our cardiovascular IV protocol includes high-dose magnesium (for coronary vasodilation and arrhythmia prevention), vitamin C (a potent antioxidant that regenerates vitamin E in arterial walls and supports collagen synthesis in vessel walls), B-complex vitamins including methylfolate and methylcobalamin (to lower homocysteine), and L-carnitine. IV sessions are typically 60–90 minutes and are administered by our nursing team under physician supervision.

IV Magnesium

High-Dose Vitamin C

Methylcobalamin

Methylfolate

IV L-Carnitine

What to Expect: Your Recovery Timeline

Weeks 1–4	Baseline advanced biomarker testing completed; personalised supplement protocol initiated; dietary modifications begun; exercise prescription provided based on stress test results.
Weeks 6–10	Most patients begin noticing reduced angina frequency and improved exercise tolerance as CoQ10, omega-3, and magnesium levels optimise. First follow-up biomarker assessment at 8 weeks.
Months 3–6	Measurable reductions in hs-CRP, ApoB, oxidised LDL, and homocysteine on repeat testing. Significant improvement in exercise capacity and quality of life in the majority of patients.
Months 6–24	Continued adherence to protocol associated with documented coronary plaque stabilisation and, in some patients, partial regression on CAC score re-testing at 12–18 months.

Lifestyle Practices for Angina Recovery

Lifestyle modifications are not supplementary to angina treatment — in functional medicine, they are primary treatment. These evidence-based practices directly modify the biological mechanisms driving coronary artery disease.

Daily Graded Walking Below Your Anginal Threshold

Begin with 10-minute walks at an intensity where you can speak in full sentences without breathlessness. Increase by 2–5 minutes per session as tolerance improves. Aim for 150 minutes of moderate aerobic activity weekly (AHA target for secondary cardiovascular prevention). Walking stimulates coronary collateral vessel development, lowers resting heart rate, reduces inflammatory markers, and improves insulin sensitivity — all protective mechanisms that directly reduce angina frequency over 8–12 weeks.

Daily Parasympathetic Activation: 4-7-8 Breathing Protocol

Practice 10 minutes of 4-7-8 breathing each morning: inhale through the nose for 4 seconds, hold for 7, exhale through the mouth for 8. This ratio activates the parasympathetic nervous system by stimulating vagal tone — measurably lowering resting heart rate, reducing cortisol, lowering blood pressure, and improving heart rate variability (HRV), which is an independent predictor of cardiovascular mortality. Start with 4 breath cycles and increase to 8 over the first two weeks to avoid dizziness.

7–9 Hours of High-Quality Sleep (Sleep Apnoea Exclusion)

Sleep deprivation acutely raises cortisol, blood pressure, and inflammatory markers — all of which worsen coronary artery disease. More critically, obstructive sleep apnoea (OSA) — present in up to 30% of angina patients — causes repetitive nocturnal hypoxia that stresses the myocardium, promotes arrhythmias, raises daytime blood pressure, and accelerates atherosclerosis. We screen all angina patients for OSA symptoms (snoring, non-restorative sleep, morning headaches) and refer for overnight oximetry or polysomnography where indicated. CPAP therapy for confirmed OSA measurably reduces cardiovascular event risk.

Complete Smoking Cessation (Within 30 Days of Diagnosis)

Smoking cessation is the single most impactful modifiable cardiovascular intervention available to angina patients who smoke. Within 24 hours of stopping, carbon monoxide levels normalise and coronary vasomotor tone improves. Within 1 year, excess coronary artery disease risk drops by 50%. Within 5 years, risk approaches that of a non-smoker. We assist smoking cessation with nicotine replacement therapy guidance and referral to evidence-based cessation programmes as part of the initial angina management protocol.

Cold Weather Exercise Precautions

Cold ambient temperature acutely constricts peripheral and coronary arteries, increases systolic blood pressure, raises myocardial oxygen demand, and substantially lowers the anginal threshold — making cold-weather outdoor exercise a disproportionately high-risk activity for angina patients. In temperatures below 40°F (4°C), exercise indoors, cover your nose and mouth with a scarf when outdoors to warm inspired air, avoid early morning outdoor exertion when temperatures are coldest, and always carry sublingual nitroglycerin or your prescribed rescue medication when exercising in cold conditions.

Moderate Alcohol Limitation (Maximum 1 Unit/Day)

While low-dose red wine was historically promoted for cardiovascular protection (via resveratrol), Mendelian randomisation studies suggest alcohol's cardiovascular benefits have been overstated. Alcohol acutely elevates blood pressure, triggers atrial arrhythmias in susceptible individuals (holiday heart syndrome), raises triglycerides, and impairs sleep quality — all of which worsen the cardiovascular risk profile in angina patients. Limit to a maximum of 1 standard drink per day with at least 2–3 alcohol-free days per week, or abstain entirely if you have concurrent arrhythmias, uncontrolled hypertension, or heart failure.

Diet & Nutrition Guide for Angina

Diet is a direct pharmacological intervention in coronary artery disease — specific foods either accelerate or decelerate atherosclerosis, inflammation, and insulin resistance, which are the three metabolic pillars supporting coronary plaque growth. The Mediterranean-DASH hybrid dietary pattern has the strongest evidence base for reducing cardiovascular events and improving angina symptoms, with the PREDIMED trial demonstrating a 30% reduction in major cardiovascular events in high-risk patients following a Mediterranean diet supplemented with olive oil or nuts.

The Single Most Important Dietary Change for Angina

Eliminate all industrially produced trans fats (partially hydrogenated vegetable oils) and drastically reduce ultra-processed food consumption. Ultra-processed foods — packaged snacks, fast food, processed meats, sugary beverages — deliver multiple atherosclerosis accelerants simultaneously: trans fats, refined carbohydrates, excess sodium, inflammatory seed oils, and advanced glycation end-products (AGEs). A single daily serving of ultra-processed food is associated with a 12% increase in cardiovascular mortality risk in prospective studies. Replace them with whole, minimally processed foods as the default.

Eat — Foods That Support Coronary Health

Extra-virgin olive oil (3–4 tbsp/day): High in oleocanthal (anti-inflammatory) and oleic acid; the cornerstone lipid in the Mediterranean diet; reduces LDL oxidation and vascular inflammation.
Fatty fish (salmon, sardines, mackerel — 3×/week): Highest dietary source of EPA and DHA omega-3 fatty acids; reduces triglycerides, lowers vascular inflammation, decreases platelet aggregation, and modestly lowers blood pressure.
Leafy greens (spinach, kale, rocket — daily): Rich in dietary nitrates that the body converts to nitric oxide — the primary vasodilator that relaxes coronary arteries and improves coronary flow reserve.
Walnuts and almonds (30g/day): Walnuts provide plant-based ALA omega-3s and polyphenols; almonds lower LDL by 5–10%; both improve endothelial function and reduce postprandial inflammation.
Berries (blueberries, pomegranate — daily): Anthocyanins and ellagic acid in berries have documented anti-atherosclerotic effects, improving endothelial nitric oxide production and reducing arterial stiffness in clinical trials.
Legumes (lentils, chickpeas, black beans — 4×/week): Soluble fibre binds LDL in the intestine; low glycaemic index stabilises blood glucose; rich in folate and B vitamins that lower homocysteine levels.
Dark chocolate ≥85% cacao (20–30g/day): Cocoa flavanols stimulate endothelial nitric oxide synthesis, lower blood pressure by 2–4 mmHg, and reduce platelet aggregation — benefits documented in multiple randomised controlled trials.
Green tea (3–4 cups/day): EGCG (epigallocatechin gallate) reduces LDL oxidation, improves endothelial function, lowers blood pressure, and reduces abdominal adiposity — with clear dose-response in prospective cohort data.
Oats and barley (daily serving): Beta-glucan soluble fibre reduces total and LDL cholesterol by 5–10% through increased bile acid excretion; independently lowers post-meal glucose spikes that trigger glycation of arterial wall proteins.

Avoid — Foods That Worsen Coronary Artery Disease

Trans fats / partially hydrogenated oils: Raise LDL, lower HDL, promote vascular inflammation, and are directly incorporated into atherosclerotic plaques; the most atherogenic substance in the food supply.
Processed meats (bacon, sausage, deli meats): High sodium content raises blood pressure; nitrite preservatives promote vascular inflammation; saturated fat content and haem iron drive LDL oxidation; associated with 42% higher cardiovascular mortality risk.
Sugary beverages (soda, fruit juice, energy drinks): Fructose-driven triglyceride synthesis, rapid glucose spikes promoting advanced glycation end-products (AGEs), and empty caloric density with no cardiovascular benefit — liquid sugar is coronary artery disease in a bottle.
Refined carbohydrates (white bread, pastries, pasta): High glycaemic index foods spike postprandial glucose and insulin, promote oxidative stress, raise triglycerides, and generate AGEs that accelerate vascular ageing and plaque formation.
Deep-fried foods: Repeated heating of cooking oils generates trans fats, aldehydes, and oxidised lipids that are absorbed and incorporated into circulating lipoproteins, increasing their atherogenicity beyond the fat's baseline risk.
High-sodium processed foods (canned soups, fast food): Dietary sodium above 1,500–2,000 mg/day raises blood pressure, promotes arterial stiffness, and increases left ventricular workload — directly worsening myocardial oxygen demand in angina patients.
Coconut oil and palm oil in excess: Very high saturated fat content elevates ApoB-containing lipoprotein particles; while not as harmful as trans fats, regular high-dose consumption raises LDL cholesterol meaningfully.
High-dose caffeine and energy drinks: Acute caffeine raises heart rate and blood pressure, increasing myocardial oxygen demand and potentially triggering angina in susceptible patients; limit to 1–2 cups of coffee daily and avoid stimulant-containing energy drinks entirely.

Related & Overlapping Conditions

Angina rarely exists in isolation — it commonly coexists with or shares pathophysiological roots with the following cardiovascular and metabolic conditions, each of which is also addressed through our integrative medicine approach at Patients Medical.

Heart Disease

Angina is the symptomatic expression of underlying coronary artery disease — the most prevalent form of heart disease. Addressing angina comprehensively requires treating the broader cardiovascular disease landscape including lipid management, inflammatory reduction, and cardiac rehabilitation.

Hypertension

Elevated blood pressure directly worsens angina by increasing cardiac workload and accelerating atherosclerosis. Up to 75% of angina patients have concomitant hypertension, and blood pressure normalisation measurably improves angina frequency and exercise tolerance.

Diabetes & Metabolic Syndrome

The most severe form of immune-mediated food reaction, coeliac is an autoimmune response to gluten involving HLA-DQ2/DQ8 genetics, anti-tTG antibodies, and villous atrophy. Distinguishing coeliac from non-coeliac gluten sensitivity (IgG-mediated) is essential because the treatment intensity and dietary strictness required differ substantially.

High Cholesterol (Dyslipidaemia)

Elevated atherogenic lipoproteins — particularly ApoB-containing particles including LDL and VLDL — are the primary lipid drivers of coronary plaque formation. Advanced lipid testing and targeted treatment are essential components of angina management.

Metabolic Syndrome

The cluster of abdominal obesity, insulin resistance, dyslipidaemia, and hypertension that defines metabolic syndrome creates a perfect storm for atherosclerosis progression — addressing all components simultaneously is essential for meaningful cardiovascular risk reduction in angina patients.

Stroke

Coronary artery disease and cerebrovascular disease share the same root causes — atherosclerosis, hypertension, and inflammation — and frequently coexist. Patients with angina have a measurably elevated risk of ischaemic stroke and require assessment of carotid artery health alongside cardiac evaluation.

When to See a Doctor About Angina

If you are experiencing chest symptoms that might be cardiac in origin, the time to seek evaluation is now — not after the symptoms have worsened or a cardiac event has occurred. Early detection and aggressive risk factor modification meaningfully changes the trajectory of coronary artery disease. Do not dismiss chest discomfort as “just stress” or “indigestion” without a thorough cardiac evaluation, particularly if you have risk factors for coronary artery disease.

Seek a Functional Medicine Evaluation If:

You experience chest tightness, pressure, or pain during exertion or stress
Chest discomfort consistently relieves when you rest for a few minutes
You have a family history of heart attack or coronary artery disease before age 65
You have diagnosed hypertension or type 2 diabetes
You have been diagnosed with angina but want a comprehensive root-cause assessment

You have shortness of breath disproportionate to your activity level
You have been told your cholesterol is borderline high or you have metabolic syndrome
You experience fatigue, jaw pain, or left arm discomfort during physical activity
Your ECG or stress test has shown abnormalities or "borderline" results
You are post-menopausal and have new-onset exertional breathlessness or fatigue

🚨 Seek Emergency Medical Evaluation Immediately If: You experience chest pain at rest lasting more than 15–20 minutes that is not relieved by nitroglycerin, chest pain accompanied by severe breathlessness, profuse sweating, vomiting, or collapse, any new or rapidly worsening chest pain unlike previous episodes, palpitations associated with lightheadedness or loss of consciousness, or any suspicion of a heart attack. Call 911 or go to your nearest emergency room immediately. Do not drive yourself. Unstable angina and myocardial infarction are time-critical emergencies where every minute of delayed treatment increases myocardial damage.

What Our Patients Say About Angina Treatment at Patients Medical

The following testimonials represent the experiences of Patients Medical patients and are shared with their permission. Individual results vary; these do not constitute medical claims.

"I had been told by two cardiologists that my angina was 'well-managed' on beta-blockers, but I was still having three or four episodes a week. Dr. Gulati ran the most thorough cardiovascular panel I've ever had — she found that my Lp(a) was extremely elevated, my hs-CRP was high, and I had significant lead burden. After six months on the protocol — CoQ10, chelation sessions, the Mediterranean diet, and a structured walking programme — my angina episodes dropped to less than one a week. My cardiologist was genuinely surprised by my repeat bloodwork."

"As a post-menopausal woman in my late 50s, I kept being told my chest tightness on exertion was anxiety. It took me two years to get a proper diagnosis of microvascular angina. The team here understood microvascular disease immediately — they explained the whole picture, ran the right tests, and put me on a supplement and lifestyle protocol that actually addressed why my tiny coronary vessels weren't working properly. Twelve weeks later I was back to hiking without symptoms. I wish I had come here sooner."

"I had a stent placed three years ago and was still having chest pressure with exertion. I came to Patients Medical wanting to understand why I was still symptomatic despite being on all the standard medications. The advanced testing revealed elevated oxidised LDL, borderline insulin resistance, and chronically elevated CRP that my standard cardiologist wasn't measuring. The integrative protocol — IV nutrients, dietary overhaul, CoQ10, omega-3s — genuinely changed my quality of life. I feel like I'm in my 40s again at 58."

Explore Our Blog For More Insights

Frequently Asked Questions About Angina

What is angina and is it a serious condition?

Angina pectoris is chest pain or discomfort caused by reduced blood flow to the heart muscle (myocardium), most commonly due to narrowed or hardened coronary arteries. It is serious because it is a warning signal that the heart is not receiving adequate oxygen during periods of increased demand, such as physical exertion or emotional stress.

While angina itself is not a heart attack, it indicates significant underlying coronary artery disease and carries a meaningful risk of progressing to myocardial infarction if left unmanaged. Stable angina follows a predictable pattern — chest pain appears during exertion and resolves with rest or nitroglycerin — while unstable angina is unpredictable, can occur at rest, and is a medical emergency requiring immediate evaluation.

The encouraging reality is that angina is highly treatable, and when the underlying coronary artery disease is addressed aggressively through lifestyle modification, targeted nutrition, appropriate supplementation, and medical therapy, many patients achieve dramatic reduction in symptom frequency and long-term cardiovascular risk. Anyone experiencing new or changing chest pain should seek prompt medical evaluation.

How long does angina treatment take to show results?

The timeline for improvement in angina symptoms through a comprehensive functional medicine programme varies depending on the severity of underlying coronary artery disease, contributing inflammatory and metabolic factors, and patient adherence to lifestyle modifications. Many patients notice a meaningful reduction in the frequency and severity of angina episodes within 6–12 weeks of beginning a structured anti-inflammatory nutritional protocol, targeted supplementation (particularly CoQ10 200–400 mg/day, omega-3 fatty acids 3–4 g/day, and magnesium glycinate 400 mg/day), and supervised exercise rehabilitation.

Biomarker improvements — including reductions in hs-CRP, LDL particle number, and oxidised LDL — typically become measurable on lab testing within 8–16 weeks. Reversal of coronary atherosclerosis is a longer process, with meaningful plaque stabilisation achievable within 6–12 months of intensive lifestyle and nutritional intervention, and partial plaque regression documented over 12–24 months in adherent patients.

Patients working with our team at Patients Medical receive follow-up cardiac testing at 3 and 6 months to objectively track their progress. This data-driven approach ensures the protocol is working and allows us to refine it based on your individual response.

What tests diagnose angina and assess my cardiovascular risk accurately?

Standard cardiology testing for angina includes a resting ECG, exercise stress test (positive in roughly 70% of cases of significant coronary artery disease), and coronary angiography when revascularisation is being considered. These tests are essential and our approach always integrates conventional cardiac assessment.

At Patients Medical, our comprehensive angina evaluation also includes advanced cardiovascular biomarker testing that standard cardiac workups frequently miss: an advanced lipid panel measuring LDL particle number, ApoB, and oxidised LDL; high-sensitivity C-reactive protein (hs-CRP) to quantify vascular inflammation; lipoprotein(a) — an independent genetic cardiovascular risk factor present in approximately 20% of the population; homocysteine (elevated homocysteine is a modifiable risk factor that accelerates arterial plaque formation); and coronary artery calcium (CAC) scoring, which uses a low-dose CT scan to directly measure calcified plaque burden in the coronary arteries.

We also assess insulin resistance, blood glucose regulation, heavy metal burden, and thyroid function — all of which directly influence coronary artery disease progression and may reveal modifiable causes that standard cardiac evaluations leave unaddressed.

Can angina cause fatigue and shortness of breath without chest pain?

Yes — atypical angina presentations without classic chest pain are common and frequently underdiagnosed, particularly in women, older adults, and people with diabetes. When the heart muscle receives insufficient blood flow, it can manifest as unexplained fatigue on exertion, shortness of breath that seems disproportionate to activity level, exercise intolerance, upper abdominal discomfort, jaw or neck pain, or a generalised sensation of heaviness or malaise — all without prominent chest pain.

This pattern, sometimes called “anginal equivalent,” is a major reason cardiovascular disease remains undertreated in women, who are statistically more likely to present with fatigue and dyspnoea than with the classic crushing chest pain associated with male presentations. In microvascular angina (Cardiac Syndrome X) — which predominantly affects post-menopausal women — breathlessness and fatigue are often the primary presenting symptoms, and normal coronary angiography results have historically led to these patients being dismissed or diagnosed with anxiety.

If you experience unexplained breathlessness, persistent fatigue during activity, or any symptoms that consistently appear with exertion and resolve with rest, a cardiac evaluation including stress testing and advanced biomarker assessment is warranted — regardless of whether classic chest pain is present.

What is the difference between angina and a heart attack?

Both angina and a heart attack (myocardial infarction) are caused by insufficient blood flow to the heart muscle, but they differ critically in duration, reversibility, and whether permanent tissue damage occurs.

In angina, blood flow is transiently reduced — typically by a coronary artery narrowed by plaque — but remains sufficient to prevent permanent muscle death. The discomfort is temporary (usually 2–15 minutes), relieves with rest or nitroglycerin, and causes no permanent cardiac muscle damage. Troponin blood tests are normal after an angina episode.

In a heart attack, a coronary artery becomes completely or near-completely blocked — usually by a ruptured plaque triggering an acute blood clot — causing permanent death of myocardial tissue. Heart attack pain is more severe, lasts longer (more than 20 minutes), does not resolve with rest or nitroglycerin, and troponin levels become elevated on blood testing. Unstable angina occupies a critical in-between position: it presents with prolonged or rest-onset chest pain without troponin elevation, but carries a very high near-term risk of progressing to full infarction and requires emergency evaluation. Any chest pain lasting more than 15–20 minutes that does not respond to nitroglycerin should be treated as a potential heart attack requiring immediate emergency care.

How does angina affect exercise capacity and physical activity?

Angina directly limits physical capacity by creating a threshold — the anginal threshold — above which myocardial oxygen demand exceeds what narrowed coronary arteries can supply. This manifests as chest tightness, breathlessness, or fatigue that consistently appears at a specific exertion level and resolves within minutes of rest. Many angina patients progressively curtail their activity to avoid triggering symptoms, creating a harmful cycle: deconditioning reduces cardiac efficiency, worsens metabolic health, increases cardiovascular risk factors, and ultimately lowers the anginal threshold further.

Supervised cardiac rehabilitation and graded aerobic exercise — conducted below the anginal threshold and gradually extended — is one of the most evidence-supported interventions for angina. Studies show that structured exercise training improves coronary collateral circulation (growing new blood supply pathways), reduces inflammatory biomarkers, lowers resting heart rate, and raises the exercise threshold at which angina occurs. The goal is to systematically improve cardiac efficiency so that activities that previously triggered symptoms no longer do so.

Our approach at Patients Medical includes personalised exercise prescription as a core component of angina management — specifying heart rate targets, duration, frequency, and progression schedule based on your individual stress test results and fitness baseline, with follow-up monitoring to adjust the programme as your capacity improves.

What supplements and natural treatments support recovery from angina?

Several well-studied nutraceuticals have demonstrated meaningful cardiovascular benefit in angina and coronary artery disease. Coenzyme Q10 (CoQ10) at doses of 200–400 mg/day supports mitochondrial energy production in cardiac cells and has been shown in clinical trials to reduce angina frequency and improve exercise tolerance. It is particularly important for patients taking statin medications, which deplete CoQ10 by inhibiting the mevalonate pathway. Omega-3 fatty acids (EPA and DHA combined, 3–4 g/day) reduce triglycerides by up to 45%, lower vascular inflammation, decrease platelet aggregation, and modestly lower blood pressure.

Magnesium glycinate (300–400 mg/day) supports coronary vasodilation, reduces arrhythmia risk, improves endothelial function, and lowers blood pressure — and deficiency is common in angina patients, partly because many cardiac medications deplete magnesium. L-carnitine (2 g/day) facilitates fatty acid transport into mitochondria and has been shown in multiple trials to reduce angina frequency and improve exercise tolerance. Berberine (500 mg twice daily) supports cholesterol and glucose metabolism through AMPK activation. Nattokinase — a fibrinolytic enzyme derived from fermented soy — may support healthy circulation by reducing fibrin accumulation.

These supplements are complementary to — not replacements for — standard cardiac medications prescribed by your cardiologist. They should never be initiated without physician oversight, as some supplements interact with cardiac medications. At Patients Medical, supplement protocols are personalised based on your specific biomarker profile and clinical history.

Ready to Understand Your Angina?

At Patients Medical, we go beyond symptom management to identify and treat every biological driver of your coronary artery disease — delivering the most comprehensive cardiovascular evaluation available in New York City, and a genuinely personalised pathway back to full cardiac health.

Call us at (212) 794-8800 · 800 Second Avenue, Suite 900, New York, NY 10017

Begin Your Journey with Patients Medical

Patients Medical specializes in gently helping the patient identify the root cause of their medical issues and then assist them to recover from their problems to help them move forward to good health.

Request your consultation today!

To schedule an in person on Tele-medicine appointment, please call our office at (212) 794-8800 or email us at info@PatientsMedical.com We look forward to hearing from you

Our medical center in New York City.

Patients Medical PC
1148 Fifth Avenue, Suite 1B New York, NY 10128

Make an Appointment

TreatmentsTesting

Please leave this field empty.